| Autor: |
Martin HA; Department of Medicine, University of California, San Francisco (UCSF), San Francisco, California, USA.; Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA., Kadiyala GN; Department of Medicine, University of California, San Francisco (UCSF), San Francisco, California, USA.; Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA., Telwatte S; Department of Medicine, University of California, San Francisco (UCSF), San Francisco, California, USA.; Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA., Wedrychowski A; Department of Medicine, University of California, San Francisco (UCSF), San Francisco, California, USA.; Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA., Chen TH; Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA., Moron-Lopez S; Department of Medicine, University of California, San Francisco (UCSF), San Francisco, California, USA.; Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA., Arneson D; Department of Medicine, University of California, San Francisco (UCSF), San Francisco, California, USA., Hoh R; Department of Medicine, University of California, San Francisco (UCSF), San Francisco, California, USA., Deeks S; Department of Medicine, University of California, San Francisco (UCSF), San Francisco, California, USA., Wong J; Department of Medicine, University of California, San Francisco (UCSF), San Francisco, California, USA.; Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA., Yukl SA; Department of Medicine, University of California, San Francisco (UCSF), San Francisco, California, USA.; Department of Medicine, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA. |
| Abstrakt: |
Most of the HIV DNA in infected individuals is noninfectious because of deleterious mutations. However, it is unclear how much of the transcribed HIV RNA is potentially infectious or defective. To address this question, we developed and validated a novel intact viral RNA assay (IVRA) that uses droplet digital reverse transcriptase PCR (dd-RT-PCR) for the commonly mutated packaging signal (Psi) and Rev response element (RRE) regions (from the intact proviral DNA assay [IPDA]) to quantify likely intact (Psi + RRE + ), 3' defective (Psi + RRE - ), and 5' defective (Psi - RRE + ) HIV RNA. We then applied the IPDA and IVRA to quantify intact and defective HIV DNA and RNA from peripheral CD4 + T cells from 9 antiretroviral therapy (ART)-suppressed individuals. Levels of 3' defective HIV DNA were not significantly different from those of 5' defective HIV DNA, and both were higher than intact HIV DNA. In contrast, 3' defective HIV RNA (median 86 copies/10 6 cells; 94% of HIV RNA) was much more abundant than 5' defective (2.1 copies/10 6 cells; 5.6%) or intact (0.6 copies/10 6 cells; <1%) HIV RNA. Likewise, the frequency of CD4 + T cells with 3' defective HIV RNA was greater than the frequency with 5' defective or intact HIV RNA. Intact HIV RNA was transcribed by a median of 0.018% of all proviruses and 2.2% of intact proviruses. The vast excess of 3' defective RNA over 5' defective or intact HIV RNA, which was not observed for HIV DNA, suggests that HIV transcription is completely blocked prior to the RRE in most cells with intact proviruses and/or that cells transcribing intact HIV RNA are cleared at very high rates. IMPORTANCE We developed a new assay that can distinguish and quantify intact (potentially infectious) as well as defective HIV RNA. In ART-treated individuals, we found that the vast majority of all HIV RNA is defective at the 3' end, possibly due to incomplete transcriptional processivity. Only a very small percentage of all HIV RNA is intact, and very few total or intact proviruses transcribe intact HIV RNA. Though rare, this intact HIV RNA is tremendously important because it is necessary to serve as the genome of infectious virions that allow transmission and spread, including rebound after stopping ART. Moreover, intact viral RNA may contribute disproportionately to the immune activation, inflammation, and organ damage observed with untreated and treated HIV infection. The intact viral RNA assay can be applied to many future studies aimed at better understanding HIV pathogenesis and barriers to HIV cure. |
